<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>28(8)</volume><submitter>Deodhar A</submitter><funding>NCATS NIH HHS</funding><journal>Journal of clinical rheumatology : practical reports on rheumatic &amp; musculoskeletal diseases</journal><pagination>420-423</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9704810</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE Study.</pubmed_title><pmcid>PMC9704810</pmcid><funding_grant_id>UL1 TR001863</funding_grant_id><pubmed_authors>Danve A</pubmed_authors><pubmed_authors>Deodhar A</pubmed_authors><pubmed_authors>Xu S</pubmed_authors><pubmed_authors>Hsia EC</pubmed_authors><pubmed_authors>Shiff NJ</pubmed_authors><pubmed_authors>Reveille JD</pubmed_authors><pubmed_authors>Chakravarty SD</pubmed_authors><pubmed_authors>Lo KH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE Study.</name><description/><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-06-21T03:19:39.023Z</modification><creation>2026-06-21T03:12:35.416Z</creation></dates><accession>S-EPMC9704810</accession><cross_references><pubmed>35649533</pubmed><doi>10.1097/RHU.0000000000001857</doi></cross_references></HashMap>